API and IP Newsletter
Contents Sun Pharma: Patent portfolio analysis Part II General information. Court Issues Notice to Serum Institute of India On Suit Against Use of Name 'COVISHIELD' For Proposed Vaccine. Piramal will expand former Ash Stevens site in Michigan . Intellectual Property. Mylan Vs Teva (T 1025/18 Pharmaceutical compositions containing Formoterol) Sun Pharma: Patent portfolio analysis Part II Below table contains information about Sun Pharma R&D activity from mid-2014 to mid-2015. Sun was very active in phase III, pre-registration and just launched molecules. Their patent portfolio seems to be very judiciously maintained and all applications which are not being worked on are abandoned in subsequent years. Sidvim comments would highlight which molecules Sun would be focusing on in the coming years. Broadly, inventions marked in green are still very interesting for Sun after 5-6 years of development and must be part of their various dossiers. Roughly, about 50 patent f